George J. Malmberg, Chief Executive Officer of Wedgewood Pharmacy, Passes Away

Mon Apr 22, 2013 8:22pm EDT

* Reuters is not responsible for the content in this press release.

George J. Malmberg, Chief Executive Officer of Wedgewood Pharmacy, Passes Away

George J. Malmberg, RPh, FACA, FACVP, co-founder and chief executive officer of Wedgewood Pharmacy, passed away on April 22, 2013 in Wilmington, Delaware following a brief illness. He was 64. With his wife and co-founder, Lucy Malmberg, RPh, FACA, FACVP, he transformed a New Jersey community pharmacy they purchased in 1981 into one of the largest specialized compounding pharmacies in the United States, with more than 230 employees serving tens of thousands of prescribers and millions of people and animals.

Malmberg was an icon in the compounding pharmacy profession, a friend and beloved mentor to many who lead and will lead the industry. He was a passionate advocate for the rights of prescribers and pharmacists to develop customized medicines for people and animals. He was generous with his time, money and talent, frequently leading efforts to defend the legal rights of compounding pharmacists and patients who need access to personalized medications. His leadership, wisdom and clarity will be sorely missed at Wedgewood Pharmacy, on the national stage and on Capitol Hill.

In 2000 he received the prestigious Albert E. Rosica, Jr. Memorial Award from the American College of Apothecaries for his outstanding contributions to pharmacy education. The pharmacy internship program at Wedgewood Pharmacy was one of many expressions of his commitment to the future of compounding pharmacy.

In 2002 he was a leader of the industry coalition of seven compounding pharmacies that argued successfully before the Supreme Court that The Food and Drug Administration Modernization Act of 1997 (FDAMA), which prohibited pharmacists from advertising or promoting compounded drugs, was a violation of their First Amendment rights. Since that time, the Malmbergs continued to lead industry efforts to protect the right of licensed prescribers to prescribe, and licensed compounding pharmacists to provide, custom-made drugs to meet the needs of individual patients.

In 2005 Malmberg was instrumental in forming the International Academy of Compounding Pharmacists' (IACP) public affairs task force, which created an advocacy program centered around Patients and Professionals for Customized Care (P2C2), a Web site that provides tools and information for advocates of compounding pharmacy to influence public policy.

In 2009, he received the highest Annual Alumni Award from the Philadelphia College of Pharmacy, given for outstanding contributions to the profession, science and mankind.

Malmberg served as a board member of the International Academy of Compounding Pharmacists (IACP) and was vice president of that organization from 1995 to 1997. From 1996 to 2001 he was a founding editor of the International Journal of Pharmaceutical Compounding. He was an adjunct faculty member and clinical instructor with the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia; and a pharmacy consultant for the patient-care review committee of Trinity Hospice, a company with 24 hospice facilities. He was a board member of the Community Pharmacy Advisory Board (Collegeville, PA), the Community Practice Advisory Board (Blue Bell, PA), and Editorial Advisory Board (Edmonds, OK).

Malmberg was a member of the New Jersey Pharmacists Association, the American Pharmacists Association, the National Community Pharmacists Association, and the International Academy of Compounding Pharmacists. He was a Fellow of both the American College of Apothecaries and the American College of Veterinary Pharmacists.

Malmberg received a B.S. degree in Pharmacy in 1972 from the Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia. He generously supported the College throughout his career.

About Wedgewood Pharmacy

George and Lucy Malmberg, both pharmacists, founded Wedgewood Pharmacy in 1981. The company has grown from a local community pharmacy to become one of the largest compounding pharmacies in the United States, serving tens of thousands of prescribers throughout the U.S. with customized animal-health and human-health prescriptions every year.

Wedgewood Pharmacy has earned the Pharmacy Compounding Accreditation Board’s (PCAB®) Seal of Accreditation, demonstrating that it meets the highest standards of quality and safety in its profession. It was the first pharmacy in the Philadelphia area to earn PCAB Accreditation, on January 31, 2012.

The company serves veterinary practices including general practices and board-certified veterinary medical specialists in Endocrinology, Ophthalmology, Theriogenology, Oncology, Cardiology and Laboratory-Animal, Equine, Feline, Zoological, Avian, Reptile and Amphibian Medicine. In human health, the company primarily serves board-certified specialists including those practicing Addiction Medicine, Dentistry, Dermatology, OB/GYN, Pre-Natal Care, Ophthalmology, Physical Therapy and Urology. The company also provides compounded preparations and placebos for clinical, investigational and translational research.

For a photo of George Malmberg, please contact DavidKirk@thePRguy.com.

Wedgewood Pharmacy
Marcy Bliss, 856-832-1303
President
MBliss@WedgewoodPharmacy.com
or
thePRguy incorporated
David Kirk, 480-382-9201
DavidKirk@thePRguy.com